Health

Dehlia Umunna appointed Clinical Professor of Law at Harvard Law

Dehlia Umunna has been appointed Clinical Professor of Law at Harvard Law School. She has been a lecturer at HLS since 2007 and is Deputy Director and Clinical Instructor at HLS’s Criminal Justice Institute (CJI), in which she supervises third-year law students in their representation of adult and juvenile clients in criminal and juvenile proceedings and arguments before Massachusetts’ Supreme Judicial Court and Appeals court. […]

Health

Pfizer, Sickle Cell Advocates Address Disease During Black Press Week

     People with rare diseases, like sickle cell disease, have unique and complex challenges and the Pfizer partnership provides an opportunity for NNPA to inform and educate readers of Black-owned newspapers in more than 70 markets across the country on sickle cell disease, which NNPA President and CEO Dr. Benjamin F. Chavis, Jr., said is an often misunderstood disease that has a profound impact on the health and well-being of those affected. […]

Health

Attorneys Ben Crump and R. Allen Smith Call Linkage Between Johnson & Johnson Baby Powder and Ovarian Cancer a Civil Rights, Public Health Crisis

Ben Crump hosted a press conference in Atlanta on Monday, February 25, 2019, in partnership with Attorney R. Allen Smith and Janice L. Mathis, Esq., executive director of National Council of Negro Women (NCNW), the oldest advocacy group for minority women, to alert women of color about evidence that shows a direct correlation between ovarian cancer and the use of Johnson & Johnson baby powder. […]

Health

Vivacelle Bio, Inc. receives FDA clearance to enroll patients into its Phase IIa Clinical Trial of VBI-1 for Severe Blood Loss and/or Raising Blood Pressure in Hypovolemic subjects

Vivacelle Bio, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase IIa clinical trial of the safety and efficacy of VBI-1. VBI-1 is a paradigm-changing cardiovascular support fluid that is designed for the treatment of patients with emergently life-threatening conditions due to blood loss and other causes of severe hypovolemia (low blood volume). […]